HLB Pharmaceutical Co., Ltd
KOE: 047920.KQ0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- KOSDAQ
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Jae-Hyung Park
- Employees
- 207
- Headquarters
- Namyangju-Si, South Korea
- IPO year
- 2015
- Market cap
- ₩537.9B
- Website
- https://www.hlbpharma.co.kr
Loading 047920…
Loading profile data…Frequently asked questions about 047920
What does HLB Pharmaceutical Co., Ltd (047920.KQ) do?
HLB Pharmaceutical Co., Ltd, a pharmaceutical company, researches and develops peptide drugs in South Korea. The company offers skeletal muscle relaxants, tranquilizers, antihistamines, antihypertensive agents, pain relief, antipruritics, astringents, anti-inflammatories, alimentary system drugs, metabolic drugs, ophthalmic agents, local anesthe...
Where does 047920.KQ trade?
HLB Pharmaceutical Co., Ltd (047920.KQ) trades on the KOSDAQ.
What sector is 047920.KQ in?
HLB Pharmaceutical Co., Ltd (047920.KQ) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of HLB Pharmaceutical Co., Ltd?
Jae-Hyung Park is the chief executive officer of HLB Pharmaceutical Co., Ltd (047920.KQ).
Where is HLB Pharmaceutical Co., Ltd headquartered?
HLB Pharmaceutical Co., Ltd is headquartered in South Korea.
Does 047920.KQ pay a dividend?
HLB Pharmaceutical Co., Ltd (047920.KQ) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did 047920.KQ go public?
HLB Pharmaceutical Co., Ltd (047920.KQ) completed its initial public offering in 2015.